Olmesartan/Amlodipin Sandoz (Olmesartan Medoxomil, Amlodipine)

Olmesartan medoxil, the active ingredient in Olmesartan/Amlodipin Sandoz, is an angiotensin II receptor blocker presented as a fixed‑dose combination for oral use. It treats hypertension in adults, often when monotherapy does not achieve target blood pressure.

GNH USA supplies Olmesartan/Amlodipin Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan/Amlodipin Sandoz is used in the management of cardiovascular conditions that involve the renin‑angiotensin system and peripheral vascular tone. - Hypertension: Improves blood‑pressure control when monotherapy is insufficient. - Chronic kidney disease with hypertension: Helps protect renal function by lowering systemic pressure. - Heart failure with reduced ejection fraction: Contributes to after‑load reduction as part of combination therapy. - Post‑myocardial infarction hypertension: Aids in secondary prevention by maintaining target pressures.

Common Side Effects: - Headache - Peripheral edema - Flushing - Dizziness - Fatigue - Nasal congestion

Serious or Rare Side Effects: - Angio‑edema - Severe hypotension - Hepatic enzyme elevation - Myocardial infarction in patients with unstable coronary disease - Acute kidney injury - Hyperkalemia

Patients should be evaluated for cardiovascular risk and renal function before initiating therapy. - Monitor blood pressure: Adjust dose if target not reached. - Assess renal function: Periodic creatinine and electrolytes are recommended. - Review concomitant antihypertensives: Avoid excessive hypotension. - Caution in hepatic impairment: Use lowest effective dose. - Pregnancy contraindication: Discontinue if pregnancy is confirmed. - Store at ambient temperature: Keep in original packaging, protect from moisture and light.

Potential interactions may vary by co‑administered medications.

Major Interactions (Avoid): - Lithium : Increased lithium levels and toxicity due to reduced renal clearance. - Alkaline alkaline alkaline Alk Al Al Al Al ");

Moderate Interactions (Monitor Closely): - ");\n- ",